GlobeNewswire Inc.··NaBiomea Fusion to Present Icovamenib Diabetes Data at ADA Conference
Biomea Fusion selected for three late-breaking poster presentations on icovamenib at ADA 86th Scientific Sessions in June 2026, showcasing Phase 2 trial results.
BMEAPhase 2 clinical trialType 1 diabetes